Načítá se...
Frailty in Hematologic Malignancy
PURPOSE OF REVIEW: Older adults with hematologic malignancy are a growing demographic. Estimating risk of chemotherapy toxicity based on age alone, is an unreliable estimate of quality of life, functional capacity, or risk of treatment complications. RECENT FINDINGS: Dedicated geriatric assessment t...
Uloženo v:
| Vydáno v: | Curr Hematol Malig Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6023762/ https://ncbi.nlm.nih.gov/pubmed/29730710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-018-0454-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|